Walleye Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Walleye Capital’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,000	Closed	-$326K	–	6159
2024 Q1	$326K	Sell	1,000 -13,900	-93%	-$3.41M	﹤0.01%	3587
2023 Q4	$2.84M	Sell	14,900 -1,900	-11%	-$359K	0.01%	1519
2023 Q3	$3.34M	Buy	16,800 +2,700	+19%	+$639K	0.01%	1334
2023 Q2	$4.02M	Buy	14,100 +11,600	+464%	+$3.22M	0.01%	870
2023 Q1	$542K	Buy	+2,500	New	+$487K	0.01%	1644
2022 Q4	–	Sell	-4,800	Closed	-$1.33M	–	3747
2022 Q3	$1.33M	Buy	+4,800	New	+$1.22M	0.03%	774

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Walleye Capital's SWAV Position: Q4 2023 in Review

Walleye Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 45,211 shares — an estimated $8.54M sold.

Walleye Capital first reported a position in SWAV in Q4 2020 and held it in 7 quarters. The position peaked at $9M in Q3 2023. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

Walleye Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Walleye Capital sold 45,211 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $8.54M.
Walleye Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Walleye Capital's Shockwave Medical, Inc. Common Stock position peaked at $9M in Q3 2023.
427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.